Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Gabriel to Chair Healthcare Reform Panel

David H. Kirkwood  |  Issue: April 2011  |  April 13, 2011

Gabriel to Chair Healthcare Reform Panel

Former ACR president Sherine E. Gabriel, MD, MSc, has long been at the forefront of patient-centered clinical research designed to enhance the effectiveness of treatment of rheumatoid arthritis and other rheumatic conditions. Now, Dr. Gabriel, who is professor of medicine and epidemiology and the William J. and Charles H. Mayo Professor at the Mayo Clinic in Rochester, Minn., has been asked to apply her expertise and leadership to improving outcomes across the full gamut of healthcare in the United States.

The researcher and clinician was selected on February 15, 2011, to chair the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). On January 21, U.S. Comptroller General Gene L. Dodaro appointed her as a member of the committee, along with 14 other physicians and scientists.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

PCORI, a nonprofit corporation, was established last year in accordance with the Patient Protection and Affordable Care Act, the centerpiece of the healthcare reform enacted in March 2010. The institute’s purpose, Dodaro stated, is “to assist patients, clinicians, purchasers, and policy makers in making informed health decisions by providing quality, relevant evidence on how best to prevent, diagnose, treat, and monitor diseases and other health conditions.”

Hours after her selection as chair, Dr. Gabriel told The Rheumatologist, “I believe PCORI and its Methodology Committee provide an unprecedented opportunity for health and medical science to play a leadership role in America’s transformation toward a high-value healthcare system. The PCORI Board of Governors will identify national research priorities and carry out a corresponding research agenda, while the Methodology Committee will develop and improve the methodological standards needed for patient-centered outcomes research, which includes methods to improve dissemination of research results.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

She adds, “This is a cause about which I am passionate. That is why I am excited and honored to be named chair of the Methodology Committee.”

Strong Support from Colleagues

The ACR and Mayo Clinic both championed Dr. Gabriel’s nomination to serve with PCORI, either on its Board of Governors—she made it to the short list of candidates—or on the Methodology Committee.

In a letter to Comptroller General Dodaro, Stanley B. Cohen, MD, also a former ACR president, wrote, “Dr. Gabriel’s expertise in both clinical practice and epidemiology has contributed to her firm understanding of population health research issues, particularly those regarding the transfer of research findings into effective methods of chronic disease prevention and treatment.” He adds that her “knowledge and expertise are impressive, but her spirit of service and her passion for patient-centered research are even more impressive.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyResearch Rheum Tagged with:Healthcare ReformLegislationPCORIResearch

Related Articles

    2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support

    January 1, 2015

    Patient Centered Outcomes Research Institute executives review PCORI’s funding, research focus and the importance of including patients as partners

    Tips for Engaging Your Pediatric Research Patients

    January 17, 2020

    ATLANTA—Around 2002, when Vincent Del Gaizo’s son was just 15 months old, he was hospitalized in an intensive care unit and, weeks later, was diagnosed with systemic juvenile idiopathic arthritis (JIA). “We had the same 8 trillion questions that all parents have when their child is diagnosed with a condition you’ve never heard of: ‘Is…

    Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA

    July 15, 2017

    CHICAGO—Sherine E. Gabriel, MD, MSc, professor of medicine at Rutgers Medical School in Newark, N.J., and a past president of the ACR, presented an overview of cardiovascular disease and rheumatology on a Saturday morning to a room overflowing with rheumatologists attending the ACR’s State-of-the-Art Clinical Symposium in April. She noted that physicians have known for a…

    Oksana Shufrych TKTK / Shutterstock.com

    Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

    October 16, 2017

    Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences